Like Peanut Butter and Jelly | GenomeWeb

Herceptin was the first, the US Food and Drug Administration says at its consumer updates page. In 1998, the agency approved the drug to treat certain breast cancers, but there had to be a diagnostic to determine what type of breast cancer a patient had. Now, the agency adds, there are 19 cleared or approved companion diagnostic tests for a range of drugs to treat certain diseases and conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.